AIF Antibody

About the Target

AIFM1 is a target of interest in many antibody-based workflows. Apoptosis-inducing factor (AIF) is a mitochondrial flavoprotein with dual roles in cellular survival and caspase-independent apoptosis. Under normal conditions, AIF resides in the mitochondrial intermembrane space, where it functions as an NADH-dependent oxidoreductase, contributing to redox metabolism, oxidative phosphorylation, and mitochondrial structure maintenance. Upon apoptotic stimuli, AIF is released from mitochondria and translocates to the nucleus, where it induces large-scale DNA fragmentation and chromatin condensation, hallmark features of apoptosis. Depending on the literature source, AIFM1 may also be discussed as AIF.

Reported cellular context includes cytoplasm, membrane, mitochondrion, and mitochondrion inner membrane, which can matter when signal is compared across treatments or changing cell states. Following AIFM1 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

AIFM1 is commonly interpreted in the context of metabolism, apoptosis, and oxidative stress research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cytoplasm, membrane, and mitochondrion, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

• apparent redistribution between cytoplasm, membrane, and mitochondrion across matched conditions
• responses linked to nutrient status, mitochondrial state, or metabolic rewiring
• separation of survival-associated changes from stress or death-associated readouts
• redox-associated shifts that may alter abundance, localization, or pathway coupling

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for AIFM1. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in AIFM1 reflect biology rather than handling. When interpreting AIFM1, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep AIFM1 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.